Curated News
By: NewsRamp Editorial Staff
September 11, 2026
Sol y Vida Clinic Launches Bilingual Telehealth to Close Latino GLP-1 Gap
TLDR
- Sol y Vida Clinic launches nationwide bilingual telehealth for medical weight loss and metabolic care in all 50 states.
- Sol y Vida Clinic offers free 20-minute consultations and licensed clinicians prescribe compounded semaglutide via telehealth in English and Spanish.
- Sol y Vida Clinic improves Latino access to metabolic care by providing bilingual telehealth and addressing a 47% prescribing gap for GLP-1 medications.
- Sol y Vida Clinic is LegitScript-certified and publishes prices, emphasizing prescribed not purchased care during Hispanic Heritage Month.
Impact - Why it Matters
This launch matters because it directly confronts a documented disparity in access to transformative metabolic treatments. Hispanic patients are significantly less likely to receive GLP-1 medications, and only a tiny fraction of eligible Latino patients access anti-obesity medications at all. By offering licensed telehealth care in Spanish across all 50 states, Sol y Vida Clinic removes language and cultural barriers that have left many patients unable to fully understand or engage with their treatment. The clinic's transparency—LegitScript certification, published pricing, and a clear stance against misleading compounded GLP-1 marketing—also raises the bar for safety in a space that has drawn FDA warnings. As Hispanic Heritage Month begins, this launch signals a push for equitable, language-concordant care that could serve as a model for addressing broader health disparities.
Summary
Sol y Vida Clinic, a Latino-founded bilingual telehealth clinic, launched nationwide on September 11, 2026, aiming to close a stark gap in metabolic medicine. According to a 2024 national cohort study, Hispanic patients are 47% less likely than White patients to be prescribed the newest GLP-1 medications, and the National Hispanic Medical Association estimates just 2% of eligible Latino patients access anti-obesity medications. With 68% of Hispanics and Latinos speaking a language other than English at home, per HHS, language barriers compound the disparity. The clinic's answer is medical weight loss and metabolic care from licensed telehealth clinicians in English and Spanish — atención médica en tu idioma — in all 50 states, opening as Hispanic Heritage Month begins September 15.
Founder Edgar Estrada said, “We created Sol y Vida to provide another option — one where patients can communicate comfortably, understand their care and have meaningful conversations with licensed healthcare professionals in the language they prefer.” The launch comes as the FDA has sent three waves of warning letters since late 2025 over telehealth marketing of compounded GLP-1 medications. Sol y Vida takes the opposite posture: it is LegitScript-certified (verifiable at legitscript.com), publishes its program prices, and its press kit lists the claims it will not make. That philosophy — “recetado, no comprado” (prescribed, not purchased) — is outlined at solyvidaclinic.com/blog/por-que-recetado-no-comprado.
Care begins with a free 20-minute first consultation, with no commitment. Licensed clinicians determine whether treatment is medically appropriate and prescribe accordingly; programs include compounded semaglutide, dispensed by licensed compounding pharmacies. Compounded medications are not FDA-approved: the FDA does not review them for safety, effectiveness or quality. Individual results vary. Headquartered in Henderson, Nevada, Sol y Vida Clinic provides care through licensed clinicians affiliated with independent medical practices in its network. Interviews in English or Spanish, Spanish-language materials and founder photography are available on request.
Source Statement
This curated news summary relied on content distributed by Noticias Newswire. Read the original source here, Sol y Vida Clinic Launches Bilingual Telehealth to Close Latino GLP-1 Gap
